ESC 365 - Latest evidence in anticoagulation for cancer-associated venous thromboembolism.

Open Access

Latest evidence in anticoagulation for cancer-associated venous thromboembolism.

Session: Evolving anticoagulation management in venous thromboembolism

Topic: Venous Thromboembolism

Speaker: Professor G. Agnelli (Perugia, IT)

Sponsored by Bristol Myers Squibb and Pfizer

Event: ESC Congress 2020

Congress Presentation

About the speaker

Professor Giancarlo Agnelli

University of Perugia, Perugia (Italy)

12 presentations

0 follower

3 more presentations in this session

The evolving landscape of anticoagulation in venous thromboembolism.

Speaker: Doctor A. Cohen (London, GB)

Anticoagulation in cancer-associated venous thromboembolism: Where are we today?

Speaker: Professor J. Connors (Boston, US)

Questions and Answers.

Speaker: Doctor A. Cohen (London, GB) Doctor J. Connors (Boston, US) Professor G. Agnelli (Perugia, IT)

Access the full session

Evolving anticoagulation management in venous thromboembolism

Speakers: Professor G. Agnelli, Doctor A. Cohen, Professor J. Connors, Doctor A. Cohen, Doctor J. Connors...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

Related content

Open Access

Definition and pathophysiological mechanisms of HFpEF.

29 August 2021

Open Access

The optimal patient pathway - how it looks like in our hospital.

28 August 2021

Open Access

Influenza and cardiovascular disease.

27 August 2021

ESC 365 is supported by